{"name":"Empros Pharma AB","slug":"empros-pharma-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Conventional orlistat 120 mg,","genericName":"Conventional orlistat 120 mg,","slug":"conventional-orlistat-120-mg","indication":"Obesity management","status":"phase_2"}]}],"pipeline":[{"name":"Conventional orlistat 120 mg,","genericName":"Conventional orlistat 120 mg,","slug":"conventional-orlistat-120-mg","phase":"phase_2","mechanism":"Inhibits pancreatic lipase to reduce fat absorption","indications":["Obesity management"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOM2xwWFMzalhuNlJncHdMejZIbzQ4Yzl3VVFrX1otTkVUcGkwOWJOOHBGMTZ0aG5YTUR3QVo5eER6dGRxOGpWR1BZNEJna2lEQnVJREU5VFVEcHotVzBZSko4WVFIbWJLZER0TzBaekwxRzR3UEhka0N5M3RhT0ZaZFh6WGtwVm9mTnI1WU9KcnljRHItSk1rdHVlWQ?oc=5","date":"2026-04-02","type":"pipeline","source":"TradingView","summary":"NET ASSET VALUE – 31 March 2026 - TradingView","headline":"NET ASSET VALUE – 31 March 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNMmE0SFA0MDlUOVBNRF9laFVQLXpuV3p0alVFZ0Fia0Zyd3hDcFkxN0dPcTR0N2xtVGU4TVoyTDdxejdWN3RUSEhFXzQxY3ZEc29pSk5zNFgtZnRmRTZoa05HMFVHNlhnQ1kwMW9YeU05NGRZNnBVWENnZmhIQ25fTDRZS3BacmVJOEZPbXpqTkE4OGdTTC1oY2JNQTc0T1ZV?oc=5","date":"2025-01-10","type":"pipeline","source":"Life Science Sweden","summary":"Life science trends 2025 – Part 1 obesity drugs - Life Science Sweden","headline":"Life science trends 2025 – Part 1 obesity drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQdGRSNHV2SG1vTjh0M01LWllIX2N1dDc4bE1BS2VWTTA5TUFWRmpmbGpsaFJ4LVJTR0V5OFd5RFhSMjlHQWxwOWNtTzNmYUFGZG0ydnU3VGdVQWl0eVBKUmZJMmszQlh0MTZ6Y3k5SHVlQl91X0h3VmdQZ3dkSXpGMThaR01CWVBJRWJhcQ?oc=5","date":"2024-09-06","type":"pipeline","source":"Precedence Research","summary":"Anti-obesity Drugs Companies | Forecast by 2033 - Precedence Research","headline":"Anti-obesity Drugs Companies | Forecast by 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxNdXBWUHJlRFYySlkzak1uSnRwYWRqUHEybXIwN2tfMUJ5LTZaclNBLUxtV0Y0LXVGOWRJS2lGVTFHbHQ5U1E4cmV1VTRick1IYWdOUGtpZEQzaV81Q1F2cWJwbUJTdUN5T2dPT0VJdjNqUjY4dmJyMjI5anMxMFBvbG02czRmVW5mYmJqekdLOVo0OG1PQXVIV0ptbFBLRkowLXpxVzYzSWg0SWZxc1hBbldndm9HcnVNZVQ2aG1vbk9ScVNwcGFhdmQzM0hkMDJGREMzSE9walBqejRnam0yc1VCMmxCM0puX1lxbkJuNDZDeDdfV3l3cFRiTHI0OVhFRWlvTUlObUtfRk5jMWt6ZjNzZ05kNXV6dkE?oc=5","date":"2024-06-07","type":"pipeline","source":"PR Newswire","summary":"Anti-Obesity Drugs Market size is set to grow by USD 18.33 billion from 2024-2028, Growing obese population boost the market, Technavio - PR Newswire","headline":"Anti-Obesity Drugs Market size is set to grow by USD 18.33 billion from 2024-2028, Growing obese population boost the ma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxOcU9UNFgxUU9QY19UdGNsZFVwNTltZ1VyUWlEX09VTzI3YkVPaUZla2lFQ245bERmMDBBbzY5eC1TZmlTMlhTTUdWdlNhSzV1cGpGTUNndWFjV2ZrV3ZMMWptZHA2bmhDTllGckplMHpNYnVscS1KMVgza1I3T1BYUVlobG4zOVc2OXkwU21iSElQbUdHRlZyVW1GS2FKY09iYzhVZ3ZId2lMNDQ3UHIwZzBTRTFRUFZmdEd3b2lVUGx3WlRCa0RKTVhiYTMwNF9Yc0ZLQnpPaF9sVjdRSHpzcGdwRGg5QTZfLTJ0THVTSUtrd0J5VXc?oc=5","date":"2022-12-20","type":"pipeline","source":"PR Newswire","summary":"Anti-obesity drugs market: Growth opportunities led by Alvogen Iceland EHF, Amgen Inc, AstraZeneca - Technavio - PR Newswire","headline":"Anti-obesity drugs market: Growth opportunities led by Alvogen Iceland EHF, Amgen Inc, AstraZeneca - Technavio","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}